GHK-Cu
A naturally occurring copper-binding tripeptide studied in tissue remodeling, skin, and wound biology.
On this page
WHAT THE EVIDENCE SAYS
GHK-Cu evidence summary.
GHK-Cu is biologically active and has limited topical human research, but the evidence does not validate broad injectable, systemic, or anti-aging claims.
01 / CLASSIFICATION
What is GHK-Cu?
Names, fragments, salts, formulations, routes, and branded products are kept distinct whenever transferring evidence would change the conclusion.
02 / EVIDENCE
GHK-Cu human and preclinical evidence.
The five-point bars describe the maturity and depth of the evidence base. They do not score effectiveness, safety, or personal suitability.
03 / STATUS
GHK-Cu FDA and sport status.
Status summaries are educational and time-sensitive. Consult current official labeling and anti-doping resources for a decision.
04 / RESEARCH AREAS
What is GHK-Cu being studied for?
05 / COMPARISONS
Compare GHK-Cu.
06 / LATEST & DEFINING SOURCES
GHK-Cu primary and official sources.
07 / QUESTIONS
Questions about GHK-Cu.
Start with identity, research, human evidence, approval, sport status, and the limits of the current record.
GHK-Cu is biologically active and has limited topical human research, but the evidence does not validate broad injectable, systemic, or anti-aging claims.
Current source-backed research areas include Skin remodeling, Wound biology, Copper signaling, Extracellular matrix. These areas describe investigation, not established personal benefit.
Current U.S. status for GHK-Cu: No FDA-approved GHK-Cu drug product identified; FDA has listed GHK-Cu among bulk substances considered by its compounding advisory process.
Current sport-status snapshot for GHK-Cu: Not specifically named in the 2026 WADA List; athletes should verify current status and product contents.
Topical cosmetic findings cannot be transferred to injected products or systemic outcomes.